MEI Pharma Reports Unregistered Equity Sale
Ticker: LITS · Form: 8-K · Filed: Jul 30, 2025 · CIK: 1262104
| Field | Detail |
|---|---|
| Company | Mei Pharma, INC. (LITS) |
| Form Type | 8-K |
| Filed Date | Jul 30, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: equity-sale, private-placement, 8-k
TL;DR
MEI Pharma sold unregistered equity, potentially diluting shares.
AI Summary
MEI Pharma, Inc. announced on July 24, 2025, an unregistered sale of equity securities. The company, incorporated in Delaware, filed this Form 8-K to report this event. The principal executive offices are located at 9920 Pacific Heights Blvd., Suite 150, San Diego, California.
Why It Matters
This filing indicates MEI Pharma has engaged in a private placement of equity, which could impact share dilution and future financing strategies.
Risk Assessment
Risk Level: medium — Unregistered sales can sometimes signal financial distress or a need for quick capital, and may involve less favorable terms for the company.
Key Numbers
- 001-41827 — SEC File Number (Identifier for MEI Pharma's SEC filings)
- 51-0407811 — IRS Employer Identification No. (Tax identification number for MEI Pharma)
Key Players & Entities
- MEI Pharma, Inc. (company) — Registrant
- July 24, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- 9920 Pacific Heights Blvd., Suite 150, San Diego, California 92121 (address) — Principal Executive Offices
FAQ
What type of equity securities were sold in the unregistered offering?
The filing states 'Unregistered Sales of Equity Securities' but does not specify the exact type of securities in the provided text.
Were there any specific terms or conditions associated with this unregistered sale?
The provided text does not detail the specific terms, conditions, or the amount of the unregistered sale of equity securities.
Who were the purchasers of these unregistered equity securities?
The filing does not identify the purchasers of the unregistered equity securities.
What is the purpose of this unregistered sale of equity securities for MEI Pharma?
The filing does not explicitly state the purpose for the unregistered sale of equity securities.
When was the Form 8-K filed with the SEC?
The Form 8-K was filed as of July 30, 2025.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 30, 2025 regarding MEI Pharma, Inc. (LITS).